CELLIMA Scientific Services’ Post

An excellent session on how the healthcare landscape is changing through AI, quantum sensing for brain imaging, medical devices and sensors, robotic surgeries and drug discovery. King's College London #healthcare

The fulfillment of Biblical Prophecy. Knowledge has definitely increased at an astounding rate.

Imagine a robot so tiny, that can navigate the complex, narrow blood vessels in our brain. MIT engineers have achieved just that with an incredibly thin, flexible robotic thread that can be magnetically guided to remove dangerous blood clots—potentially saving lives & minimizing the damage caused by strokes. Stroke is one of the top causes of death and disability. The earlier it’s treated, the higher the chances of survival and recovery. This robotic thread could change the game by allowing doctors to treat clots remotely and rapidly, even within the critical “golden hour” after a stroke. Developed by MIT, it is made of a nickel-titanium alloy, which is both flexible and springy, allowing it to “thread” through complex pathways. Coated with hydrogel, it glides through vessels without causing friction or injury to vessel walls. Using a powerful magnet, doctors can steer the thread to the exact location of the clot, where it can then deliver clot-busting drugs or even break down blockages with a laser! This technology could be a game-changer for surgeons. With remote-controlled magnets, doctors can operate from outside the room—away from radiation exposure and potentially even across long distances. This work, published in the journal "Science Robotics": https://lnkd.in/eqvjCcCE clip credits: techthatmatters Follow for more interesting updates in AI, Robotics, and Innovation: Arpit Singh • • #robotics #healthcare #engineering #ai #technology

Thrombotic strokes are responsible for about half of all strokes. They occur when a blood clot forms within an artery that supplies blood to the brain. When these blood vessels become blocked by a clot, oxygen can’t reach the parts of the brain that need it, which causes a stroke. What Causes Blood Clots to Form in Blood Vessels? Here are some common factors: 🤐 Atherosclerosis and High Cholesterol: One of the main causes of clot formation in blood vessels is atherosclerosis, which is the buildup of fatty deposits, called plaques, on the inner walls of blood vessels. 💣 High Blood Pressure: Hypertension (high blood pressure) damages blood vessels by creating tiny tears in their walls. This can also make the blood vessels more likely to attract platelets and start the clotting process. 💥 Diabetes and High Blood Sugar: High blood sugar levels contribute to inflammation, which makes the blood vessels more vulnerable to plaque buildup and clotting. 💨 Smoking Now, let’s imagine how a clot forms inside an artery over time, especially in someone with risk factors like high cholesterol, high blood pressure, or diabetes: 💛 Plaque Formation: As cholesterol and fats accumulate on the artery walls, they form a sticky plaque. Think of it like scum building up on the inside of a water pipe. Blood can still flow, but there’s less space for it to pass through, and the surface of the artery wall becomes rough. 💚 Platelet Gathering: When platelets come into contact with the rough plaque surface, they stick to it and begin clumping together. This is similar to how snowballs get bigger when rolling—over time, the buildup grows larger. 💙 Fibrin Weaving: Fibrin, a protein in the blood, then weaves through the platelet clump, creating a thick, tangled mass that strengthens the clot. This is how a small cluster of platelets can become a firm clot. 💜 Growth of the Clot: The clot continues to grow as more platelets and fibrin are added, gradually narrowing the artery even more. 🖤 Stroke Occurs: Once the artery is fully blocked, blood can no longer reach the brain tissue supplied by that artery. Without blood, oxygen can’t get to the brain cells, and they start to die quickly. This cell death causes the symptoms of stroke, such as weakness on one side of the body, difficulty speaking, or loss of coordination. Thrombotic stroke requires fast treatment to limit brain damage. Treatments for stroke include medications like clot-dissolving drugs, which can help break down the clot if administered quickly after the stroke begins. Some patients may also need procedures to physically remove the clot called MECHANICAL THROMBECTOMY. That's where technology can make things better,..read on...

A team at Cornell University created robots smaller than bacteria that can walk, swim, and manipulate light for imaging deep inside biological tissues.

These are tiny robots capable of manipulating single cells that are 30 to 40 micrometers in size with high precision! The microrobots can grip, move, and even rotate individual cells. The field of single cell imaging has already been booming, and this technology might offer for imaging single cells and manipulating their interactions even more. This could lead to enabling effective handling of cells in various biological and medical applications. Just a scientific marvel for the day.

We’re starting the last day of the Cochlear Implant Society conference with a talk by our very own Martin Brand. Prof is educating the audience on artificial intelligence with the topic being, “With the rise of artificial intelligence systems and robots, are doctors an endangered species?” “Is the writing on the wall for human doctors? This presentation documents artificial intelligence and robotic advances in medicine, from clinical management applications to medical safety, simulation training and autonomous surgeon robots; highlighting pro’s and cons of these with examples. Concluding with how robots can never replace humans.” #doctors #ENT #audiologists #speechtherapists #ethics #education #continuousprofessionaldevelopment Genoa Underwriting Managers

Robot-assisted feeding system: Revolutionary advancement for patients with mobility disorders Researchers at the Cornell University have developed an advanced robotic feeding system that uses computer vision, machine learning and multimodal sensing to safely feed people with severe mobility limitations, including those with spinal cord injuries, cerebral palsy and multiple sclerosis. To combat existing challenges, developers outfitted their robot with real-time mouth tracking that adjusts to users' movements, and a dynamic response mechanism that enables the robot to detect the nature of physical interactions as they occur, and react appropriately. This enables the system to distinguish between sudden spasms, intentional bites and user attempts to manipulate the utensil, thus providing an effective feeding mechanism. It is amazing and very fulfilling. While further work is needed to explore the system’s long-term usability, its promising results highlight the potential to improve care recipients’ level of independence and quality of life"-Dr. Bhattacharjee #CCA #Robocell #RoboticsResearch #MedicalTechnology #InnovationInMedicine

Elon Musk’s company, Neuralink, has announced a new feasibility trial to test its brain implant for controlling a robotic arm using thought alone. The trial will extend the capabilities of the N1 brain-computer interface (BCI). BCIs enable direct control of external devices by decoding brain waves and interpreting movement signals from neurons, helping in assistive technology. Neuralink shared the news on social media platform X, marking a significant step forward in testing the N1 implant for practical and assistive robotic applications. #Techwixer #Elon #Musk #Robotic #Neuralink #Technology #Tech #Devices

Robotics augment our capabilities to stimulate the brain non-invasive with high precision. With multi-locus #TMS and robotics, we reduce the need for operator intervention and automate the brain stimulation process. This makes the process faster and safer, with the mTMS coils automatically placed on the scalp and the #brain precisely and scanned through our #InVesalius #neuronavigation. Our paper in Brain Stimulation: https://lnkd.in/dPZm978K The technical characterization of our system is available in bioRxiv & medRxiv: https://lnkd.in/d_ccqFqH Renan Matsuda, Thais Marchetti, Ana María Soto de la Cruz, Olli-Pekka Kahilakoski, Andrey Zhdanov, Victor Malheiro, Mikael Laine, Mikko Nyrhinen, Heikki Sinisalo, Dubravko Kičić, Pantelis Lioumis, Risto Ilmoniemi, Oswaldo Baffa Aalto University and USP - Universidade de São Paulo